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The 1918 H1N1 inﬂuenza virus was responsible for one of the most deadly pandemics in human history.
Yet to date, the structure component responsible for its virulence is still a mystery. In order to search for
such a component, the neuraminidase (NA) antigen of the virus was expressed, which led to the dis-
covery of an active form (tetramer) and an inactive form (dimer and monomer) of the protein due to
different glycosylation. In this report, the N-glycans from both forms were released and characterized by
mass spectrometry. It was found that the glycans from the active form had 26% core-6 fucosylated, while
the glycans from the inactive form had 82% core-6 fucosylated. Even more surprisingly, the stalk region of
the active form was almost completely devoid of core-6-linked fucose. These ﬁndings were further
supported by the results obtained from in vitro incorporation of azido fucose and 3H-labeled fucose using
core-6 fucosyltransferase, FUT8. In addition, the incorporation of fucose did not change the enzymatic
activity of the active form, implying that core-6 fucose is not directly involved in the enzymatic activity. It
is postulated that core-6 fucose prohibits the oligomerization and subsequent activation of the enzyme.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
The 1918 inﬂuenza, or “Spanish Flu” virus, caused the most
devastating pandemic in recorded human history. Its estimated
infection rate lies between 25% and 30% of the 1918 global popu-
lation with approximately 50e100 million deaths worldwide [1].
Currently, inﬂuenza is an ongoing threat to human society [2,3],
having caused the recent pandemics of the 2005 Hong Kong avian
ﬂu [4] and 2009 swine ﬂu [5]. Research on the 1918 inﬂuenza virus
may provide key insights for combating the emerging strains of
inﬂuenza virus. For this reason, the 1918 inﬂuenza virus (A/Brevig
Mission/1/18) was resurrected from the body of an Alaskan Inuit
woman in 2005 [6]. Signiﬁcant effort has been made to decipher
the mechanism of the lethality of this virus since then.
Inﬂuenza virus has two surface antigens, hemagglutinin (HA)
and neuraminidase (NA) [7]. HA initially recognizes and binds to
the terminal sialic acid residue on a host cell surface to mediate
viral infection and infusion [5]. NA subsequently hydrolyzes hostWu), Vernon.Reinhold@unh.
r Inc. This is an open access articlsialic acid residues to allow release of the progeny virus and spread
of the infection [8]. NA is a box-shaped tetrameric glycoprotein
with a large and globular head, a stalk region, and a small hydro-
phobic region that anchors the antigen into the viral lipid mem-
brane [8]. The stalk region of the NA from the 1918 inﬂuenza virus
contains approximately 50 amino acid residues (aa40eaa90) and is
responsible for the oligomerization of the protein [8].
The active site of NA is highly conserved throughout all inﬂu-
enza viruses [9], and this has allowed the development of two
enzyme-inhibitor based anti-ﬂu drugs: Tamiﬂu and Relenza [10].
Despite this success, our understanding of NA regulation remains
limited, particularly regarding the biological functions of NA
glycosylation. Previously, the expression of the 1918 inﬂuenza viral
NA resulted in isolation of both active tetramer and inactive dimer/
monomer forms [11]. The inactive form was unable to oligomerize
to the active form, suggesting intrinsic molecular differences
among the two forms. Subsequently, the N-glycans on the two
forms were found to be different. Herein, we further characterize
the N-glycans from the two forms by mass spectrometry and
in vitro glycosylation study. Mass spectrometry analysis revealed a
striking difference between the levels of core-6 fucosylation, where
the overall level of core-6-linked fucosylation was signiﬁcantly
lower in the active form accompanied by almost complete absence
of core-6-fucose within its stalk region. This discovery was furthere under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Fig. 1. (A) The sequence of the expressed 1918 H1N1 NA contains seven potential N-
glycosylation sites. Five sites (N-50 to 88) reside in one large tryptic peptide (6xHis tag
and S-37 to K-102, underlined) that is a part of the stalk region of the protein. The
amino acid sequence numbering is according to GenBank AAF77036. (B) SDS-PAGE of
the tetramer NA (T) and dimer NA (D), both reduced and alkylated. Bovine fetuin (Fet)
in native from and reduced/alkylated form was separated in the same gel as a reso-
lution control. The form in reduced/alkylated was up-shifted, due to the carbamido-
methylation of six pairs of disulﬁde bonds.
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fucose that was detected via click chemistry [12] and radio-labeled
fucose at core-6 position using recombinant fucosyltransferase 8
(FUT8).
2. Results
2.1. Tetramer and dimer contain similar amount of total N-glycan
Previously, the pandemic 1918 H1N1 inﬂuenza viral NA was
expressed and puriﬁed in an active form and an inactive form [11].
The expressed sequence contains seven potential N-glycosylation
sites and ﬁve of them reside in a single tryptic peptide within its
stalk region (Fig. 1A). It was found that the glycosylation was
intrinsically different between the two forms. To further investigate
this difference, the two forms were ﬁrst separated on SDS gel after
reduction and alkylation (Fig. 1B). It was clear that the two forms
had similar mobility around 53 kDa, while the theoretical mass is
48.3 kDa, again suggesting that the difference is structural.
2.2. N-glycans of the tetramer and dimer NA possess different levels
of fucosylation
To further investigate the difference on glycosylation, the N-
glycans of the two forms were released and analyzed with MALDI-
MS (Fig. 2A and B). The mass spectra showed simple pauci- and
high-mannose type glycans. In the spectrum of the tetramer, the
most dominant peak (m/z 935.36, Hex3HexNAc2) was from a
pentasaccharideMan3GlcNAc2 [13], and the second dominant peak
at much less abundance (m/z 1081.43, Hex3HexNAc2Fuc1) was
from a fucosylated glycan Man3GlcNAc2Fuc1. Surprisingly, in the
spectrum of the dimer, the fucosylated glycan (m/z 1081.42,
Hex3HexNAc2Fuc1) became the most dominant peak, and the non-
fucosylated glycan (m/z 935.33, Hex3HexNAc2) became much less
abundant. Since all detected glycans were neutral and similar in
size, the relative abundance of individual composition within each
sample should be proportional to its peak intensity in each MALDI-
MS spectrum [14]. Based on this assumption, the non-fucosylated
compositions were calculated to account for 81.89% of the total
glycans in the tetramer, and 26.40% of the total glycans in the dimer
(Supplemental Table 1).
Since the stalk region that is highly enriched with N-glycosyl-
ation sites is involved in the oligomerization of the protein [8] and
possibly protecting the protein from host cell protease attack [11],
different glycosylation on this region is likely to affect these func-
tionalities. For this reasoning, the tryptic peptides of the stalk re-
gion of the two forms were further isolated and analyzed with
MALDI-MS. Even more surprisingly, the glycans of the stalk re-
gion of the active tetramer were found to be almost completely
devoid of fucosylation (Fig. 2C), while those of the inactive form
were largely fucosylated (Fig. 2D).
2.3. Locate the positioning of fucosylation via MSn fragmentation
To locate the position of the fucosylation, the permethylated N-
glycans from both forms were subjected to ESI-MSn fragmentation
[15,16]. When the fucosylated composition (Hex3HexNAc2Fuc1)
from the tetramer was analyzed, the fucose residuewas found to be
linked to the reducing end GlcNAc of the oligosaccharide Man3-
GlcNAc2Fuc1 (Supplemental Fig. 1). Given that the N-glycans were
enzymatically released by PNGase F that lacks activity on core-3-
linked fucosylated N-glycans [17], the fucose residue must be at
the 6-O position of the reducing end GlcNAc residue.
To this end, the most abundant composition (Hex3HexNAc2) of
the tetramer was conﬁrmed to be a typical core pentasaccharide(Man3GlcNAc2) (Supplemental Fig. 2). When equivalent composi-
tions from the dimer were analyzed, identical structures were ob-
tained (data not shown). Overall, MS analysis clearly indicated that
the level of core-6-linked fucosylation was the major difference
between the N-glycans of the two forms of NA.
2.4. Probing core-6 fucosylation using click chemistry and tritium-
labeled fucose
Core-6 fucosylation of the reducing-end GlcNAc on N-glycans is
introduced by FUT8 in humans [18]. To conﬁrm the results of mass
spectrometry analysis, the levels of core-6 fucosylation were
further probed with azido fucose using recombinant human FUT8.
The incorporated azido fucose was then conjugated to a biotin
residue via a click chemistry reaction [19,20], and detected with
streptavidin-conjugated horse radish peroxidase [21,22]. As shown
in Fig. 3A, same amount of the tetramer accommodated signiﬁ-
cantly more azido fucose than the dimer. When the core-6 fuco-
sylation was probed with 3H-fucose using FUT8, again, the active
tetramer incorporated signiﬁcantly more 3H-fucose compared to
the dimer (Fig. 3B).
Considering that the two forms of NA had similar amount of
total glycans (Fig. 1B), the results in Fig. 3 again suggest that the
active tetramer had signiﬁcantly more non-fucosylated glycans
than the inactive dimer.
Fig. 2. MALDI-MS of N-glycans (reduced to alditols) from tetramer NA (A) and dimer NA (B), and N-glycans (native, non-modiﬁed) from the stalk region of tetramer NA (C) and
dimer NA (D). The plausible topology of each peak was proposed based on the bio-synthetic knowledge of N-glycosylation and its m/z value. All ions are single sodium adducts. (*
Impurities or possible peptides).
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activity
Given that the active NA had signiﬁcant lower level of core-
fucosylation than that of the inactive form, it is imperative toinvestigate whether in vitro fucosylation will inactive the active
form. To answer this question, the active tetramer was fucosylated
using FUT8 for different time lengths before its activity was
measured. Surprisingly, the enzymatic activity remained constant
along the course (Fig. 4).
Fig. 3. Probing the levels of core fucosylation on the two forms of 1918 H1N1 neur-
aminidase through in vitro fucosylation. In all experiments, equal amounts of dimer
and tetramer were used for comparison. (A) The tetramer and dimer were fucosylated
with azido-fucose by FUT8 and FUT11. The substrate speciﬁcity of FUT11 was unknown
and used as a negative control. The incorporated azido-fucose was probed with
streptavidin-HRP via click chemistry reaction. (B) Fucosylation of the dimer and
tetramer with 3H-fucose by FUT8. The samples were spotted on glass ﬁber ﬁlters and
counted with a liquid scintillation counter.
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Fig. 4. Effect of in vitro fucosylation on the enzymatic activity of the active form of
1918 H1N1 neuraminidase. The active tetramer was fucosylated in vitro using re-
combinant human FUT8 for different length of time and then activity was measured.
Activity was plotted versus the time of reaction.
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Previously, 1918 inﬂuenza viral NA was expressed as two
inconvertible forms, i.e. active and inactive forms, suggesting an
intrinsic difference between the two forms. In this report, using
mass spectrometry and in vitro fucosylation, we demonstrated that
the inactive form is highly core-fucosylated, whereas the active
form is mainly devoid of core fucose. However, in vitro core-
fucosylation of the active form didn't abolish its activity, suggest-
ing that there is no direct link between core-fucosylation andenzymatic activity.
Core-fucose is known to be involved in several biological events.
One well-known example is antibody-dependent cell-mediated
cytotoxicity (ADCC), where core-fucose inhibits carbohy-
drateecarbohydrate interactions between the antibody and its re-
ceptor FcgRIIIa [23]. Antibodies lacking core fucosylation show a
large increase in afﬁnity for FcgRIIIa, leading to an improved
receptor-mediated effector function [24]. Core fucosylation of N-
glycans is also required for the binding of EGF to its receptor, sug-
gesting core fucosylation is critical to EGF mediated intracellular
signaling [25]. In the case of 1918 inﬂuenza viral NA, considering
that the stalk region is heavily glycosylated and play roles in the
process of oligomerization, it is likely that the core-fucosylation in
this region weakened the carbohydrateecarbohydrate interaction
so that it prevented the tetramerization but allowed the formation
of dimer, and explains the earlier observation that the monomer
and dimer were convertible but not the tetramer [11].
Fucosylation is ubiquitous and age related [26]. For example,
older people (>60 years old) has higher level of fucosylated
haptoglobin compared to younger people (<40 years old) [27]. In a
mouse model, it has been reported that the expression of Fut8 is
up-regulated with age [28]. If core-fucosylation indeed inhibited
the oligomerization and the activation of the neuraminidase of the
1918 pandemic inﬂuenza virus, people with higher level of FUT8
activity would have been advantageous for survival during the
pandemic. Therefore, together with the age speciﬁc expression of
core-fucose, the current ﬁnding may explain the mystery of the
1918 pandemic inﬂuenza, i.e. it caused a relatively lower death rate
among the older population, while the younger population expe-
rienced a higher death rate [29]. Accordingly, if core-fucosylation is
a general mechanism for inhibiting the oligomerization of inﬂuenza
viral neuraminidases, it will be a good target for inﬂuenza drug
development.4. Materials and methods
Ammonium bicarbonate, dithiothreitol (DTT), iodoacetamide
(IAA), triﬂuoroacetic acid (TFA), sodium hydroxide (NaOH),
dimethyl sulfoxide (DMSO), iodomethane (CH3I), sodium borohy-
dride (NaBH4), 2,5-dihydroxybenzoic acid (DHB), urea, cellulose
(medium ﬁbrous), trypsin, HPLC grade ethanol, 1-butanol, and
GDP-fucose were from SigmaeAldrich. Sep-Pak C18 SPE cartridge
was from Waters. PNGase F was from New England Biolabs. The
NuPAGE series of LDS sample buffer (4), MOPS SDS running buffer
(20), SimplyBlue SafeStain and 4e12% Bis-Tris Gels were from Life
Technologies. 10,000 MWCO centrifugal devices were obtained
from Millipore. NA was expressed with N-terminal His tag in sf21
insect cells and puriﬁed using nickel-histidine afﬁnity chromatog-
raphy followed by gel ﬁltration as previously described [11]. Re-
combinant FUT8, FUT11, GDP-azido-fucose, biotinylated alkyne,
and streptavidin-HRP were from R&D Systems.4.1. Sodium dodecyl sulfate polyacrylamide gel electrophoresis
(SDS-PAGE)
The active tetramer and inactive dimer of the puriﬁed 1918
H1N1 NA were ﬁrst reconstituted in 8 M urea/0.4 M ammonium
bicarbonate. Both samples were then reduced by 25 mM DTT
(45min at 50 C), and alkylated by 40mM IAA (30min at 23 C) in a
dark environment. An aliquot of 2 mg of each form was mixed with
LDS sample buffer and loaded onto a 4e12% Bis-Tris gel. SDS-PAGE
was performed using MOPS SDS buffer and protein was stained
with SimplyBlue SafeStain according to the vendor's protocol.
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of stalk region
The aliquots of both reduced and alkylated forms (tetramer and
dimer) of NA were incubated with trypsin overnight at a weight
ratio (1/25: trypsin/NA) in a 37 C oven. The proteolytic digestion
was stopped by the addition of TFA into the samples in an ice bath.
Large polypeptide-containing stalk regions from both samples
were enriched via YM-10 centrifugal ﬁlters. Brieﬂy, the mixture of
crude tryptic peptides was re-dissolved in 500 mL of HPLC water
and transferred into the sample chamber of a centrifugal ﬁlter.
Small peptides were removed by repeated centrifugation (2), and
the retained fraction in the sample chamber was collected as the
stalk region tryptic peptide as described in the Results section.
Peptides were further desalted by passage through C18 SPE [30].
4.3. Sample preparation of released N-glycans
The desalted peptides, either from tryptic digestion of 150 mg of
an NA sample or its equivalent amount of puriﬁed stalk region,
were re-dissolved in 5 mL of 500 mM sodium phosphate (pH 7.5)
and 45 mL of HPLC water. Each sample was then digested with 2 mL
PNGase F at 37 C for 1 h. The released N-glycans were separated
from peptides on a second C18 SPE using 5% ACN/0.1 TFA as elution
buffer. When required, N-glycans were further reduced to the
corresponding alditols by the addition of 200 mL of NaBH4 (10 mg/
mL in 0.01 M NaOH). The reduced N-glycans were puriﬁed using
hand-packed cellulose cartridges [15] and permethylated [31] for
MSn analysis.
4.4. Mass spectrometry
MALDI-MSwas carried out on aMALDI-TOF instrument (MALDI-
CFR, Shimadzu), with a nitrogen laser at 337 nm. External calibra-
tion was performed using the ProteoMass Peptide MALDI-MS
calibration kit (SigmaeAldrich). The matrix solution was prepared
by dissolving 10 mg of DHB in a volume of 1 mL of 50% acetonitrile
containing 2 mM sodium acetate. N-Glycans were directly spotted
onto a stainless steel plate and mixed with an equal volume of
matrix solution (0.5e1 mL). TheMALDI-MS spectrawere acquired in
the positive reﬂectron mode from 600 to 5000 Da. The laser energy
(power) was manually adjusted to obtain best signals (80e120). A
minimum of 1500 scan were averaged for each spectra using the
Spectrum Contents within the application Launchpad (v2.8.4, Shi-
madzu Biotech). ESI-MS and ESI-MSn of permethylated N-glycans
were carried out on a Thermo linear ion trap instrument LTQ
(Thermo Fisher Scientiﬁc) equippedwith direct chip-based infusion
(Triversa Nanomate). The ESI source voltage was set at 2.0e2.5 kV,
and the capillary temperature at 230 C. MS spectra were acquired
from m/z 500e1800 with a minimum of 30 scan. MS/MS and MSn
spectra were performed using a normalized collision energy at 35%,
activation Q at 0.25, and activation time of 30 ms. All scans of one
spectrum were accumulated by Xcalibur 2.0.
4.5. Neuraminidase activity assay
The activity assay previously described [11] was followed. The
NA enzyme was ﬁrst diluted with an assay buffer (50 mM Tris,
5 mM CaCl2 and 200 mMNaCl at pH 7.5) to a concentration of 1 ng/
mL. To start the reaction, 50 mL of the diluted enzyme was mixed
with 50 mL of 400 mM substrate 20-(4-methylumbelliferyl)-a-D-N-
acetylneuraminic acid (SigmaeAldrich) in a 96-well ﬂuorescent
plate. The reaction kinetics was monitored by ﬂuorescence at
excitation of 365 nm and emission of 445 nm in a SpectraMax
Multi-Mode Microplate Reader (Molecular Device).4.6. In vitro enzymatic fucosylation
Enzymatic fucosylation was carried out by combining 1 mg of
substrate (dimer or tetramer NA) with either 2 mL of GDP-3H-fucose
(1.2 mM from Perkin Elmer) or 5 nmol of GDP-fucose, and 0.5 mg of
recombinant human FUT8 in 20 mL of 10 mM Tris (pH 7.0) and
10 mM MnCl2. The reaction was then incubated at room tempera-
ture for required length of time.
4.7. Filter binding assay
Following 3H-fucose incorporation, 8 mL from each reaction was
spotted on a type GF/C glass ﬁber (Fisher Scientiﬁc). Ethanol (75%)
was dropped to these spots to denature the protein. The ﬁlters were
dried and then thoroughly washed in 200 mL of water in a shaker
for 5 min. The ﬁlters were ﬁnally counted with an LS 6500 scin-
tillation counter in Ready Protein™ cocktail (Beckman Coulter).
4.8. Probing the core-6 fucose on the two forms of NA with azido
fucose
The general procedure of glycoprotein labeling with click
chemistry (GLCC) [21] was followed to probe core-6 fucosylation
with recombinant human FUT8. The dimer NA at 95 ng/mL or the
tetramer NA at 70 ng/mL was incubated with 30 ng/mL of FUT8, or
40 ng/mL of FUT11, plus 0.08 mM GDP-azido-fucose in 25 mM Tris
(pH 7.5), 150 mM NaCl, and 4 mM MnCl2 at 37 C for 90 min. To
initiate the click chemistry reaction, 100 mM biotinylated alkyne,
100 mM CuCl2, and 2 mM ascorbic acid were added to the mixtures,
and followed by incubation at room temperature for 1 hour. One mg
each of fucosylated NA samples was loaded per well onto a 12%
SDS-PAGE gel containing 2,2,2-Trichloroethanol. The gel was run at
50 mA, imaged via the method of Ladner, C.L. et al. [32], and further
electro-transferred onto nitrocellulose membrane at 25 V for
30 min. The blot was then blocked with 10% milk, washed thor-
oughly with TBS buffer (25mM Tris, pH 7.6, 137 mMNaCl and 0.01%
Tween), incubated with 75 ng/mL streptavidin-HRP in 25 mM Tris,
150 mM NaCl, pH 7.5 for 30 min, washed three times in TBS for a
total of 30 min, incubated with ECL chemiluminescent substrate
(Thermo Scientiﬁc) brieﬂy, and then exposed to an X-ray ﬁlm for
20 s.
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Abbreviations
HA hemagglutinin
NA neuraminidase
Hex hexose
HexNAc N-acetyl hexosamine
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Man mannose
GlcNAc N-acetyl glucosamine
MALDI matrix-assisted laser desorption/ionization
MS mass spectrometry
ESI electrospray ionization
MSn sequential mass spectrometry fragmentation (n > 2)
FUT8 fucosyltransferase 8
FUT11 fucosyltransferase 11
RFU relative ﬂuorescent unit
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